Ann Sturdy
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- Tuberculosis Research and Epidemiology 3
- COVID-19 Clinical Research Studies 1
- Infection Control in Healthcare 1
-
- Nosocomial Infections in ICU 1
- Co-authors
- Laurence John (2 shared papers)Graham Cooke (2 shared papers)Martin J Dedicoat (1 shared paper)Anna L. Goodman (1 shared paper)Angela Loyse (1 shared paper)Ricardo Jorge Paixão José (1 shared paper)Onn Min Kon (1 shared paper)Marc C.I. Lipman (1 shared paper)
- Journals
- The Lancet (3 papers)The International Journal of Tuberculosis and Lung Disease (2 papers)Journal of Hospital Infection (1 paper)Thorax (1 paper)The Lancet Infectious Diseases (1 paper)
- Partner nations
- United KingdomItalyAustralia
In The Last Decade
Ann Sturdy
10 papers receiving 5.1k citations
Ann Sturdy's Hit Papers
Peers
Comparison fields: 5 of 118
- Infectious Diseases 3.9k
- Modeling and Simulation 292
- Health 355
- Toxicology 94
- Applied Microbiology and Biotechnology 41
Countries citing papers authored by Ann Sturdy
This map shows the geographic impact of Ann Sturdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Sturdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Sturdy more than expected).
Fields of papers citing papers by Ann Sturdy
This network shows the impact of papers produced by Ann Sturdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Sturdy. The network helps show where Ann Sturdy may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Sturdy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3698 |
| 2 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 894 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 4 | 2022 | 138 | |
| 5 | 2011 | 78 | |
| 6 | 2022 | 52 | |
| 7 | 2020 | 42 | |
| 8 | 2023 | 6 | |
| 9 | 2024 | 4 | |
| 10 | 2020 | 2 | |
| 11 | 2016 | 0 |
About Ann Sturdy
Ann Sturdy is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, Rheumatology and Nuclear Energy and Engineering, having authored 11 papers that have together received 5.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Tuberculosis Research and Epidemiology (3 papers), Infection Control and Ventilation (1 paper), Nosocomial Infections in ICU (1 paper), Pulmonary Hypertension Research and Treatments (1 paper), Eosinophilic Disorders and Syndromes (1 paper), COVID-19 Clinical Research Studies (1 paper) and Infection Control in Healthcare (1 paper). The work is most often cited by research in Infectious Diseases (3.9k citations), Modeling and Simulation (292 citations), Health (355 citations), Toxicology (94 citations) and Applied Microbiology and Biotechnology (41 citations). Ann Sturdy has collaborated with scholars based in United Kingdom, Italy and Australia. Frequent co-authors include Laurence John, Graham Cooke, Martin J Dedicoat, Anna L. Goodman, Angela Loyse, Ricardo Jorge Paixão José, Onn Min Kon, Marc C.I. Lipman, Thomas Stephen Harrison and David Conover Spray. Their work appears in journals such as The Lancet, The International Journal of Tuberculosis and Lung Disease, Journal of Hospital Infection, Thorax and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.